FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

37949711000001108: Upadacitinib hemihydrate (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 28-Sep 2022. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    576581000001110 Upadacitinib hemihydrate en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    576591000001112 Upadacitinib hemihydrate (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Upadacitinib hemihydrate Is a Upadacitinib false Inferred relationship Existential restriction modifier
    Upadacitinib hemihydrate Is a Upadacitinib false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Upadacitinib 30mg modified-release tablets Has specific active ingredient False Upadacitinib hemihydrate Inferred relationship Existential restriction modifier
    Upadacitinib hemihydrate 15mg tablets Has specific active ingredient False Upadacitinib hemihydrate Inferred relationship Existential restriction modifier
    Rinvoq 15mg modified-release tablets (AbbVie Ltd) Has specific active ingredient False Upadacitinib hemihydrate Inferred relationship Existential restriction modifier
    Rinvoq 15mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient False Upadacitinib hemihydrate Inferred relationship Existential restriction modifier
    Upadacitinib hemihydrate 15mg tablets 28 tablet Has specific active ingredient False Upadacitinib hemihydrate Inferred relationship Existential restriction modifier
    Upadacitinib 15mg modified-release tablets Has specific active ingredient False Upadacitinib hemihydrate Inferred relationship Existential restriction modifier
    Rinvoq 15mg modified-release tablets (AbbVie Ltd) Has specific active ingredient False Upadacitinib hemihydrate Inferred relationship Existential restriction modifier
    Upadacitinib 15mg modified-release tablets 28 tablet Has specific active ingredient False Upadacitinib hemihydrate Inferred relationship Existential restriction modifier
    Rinvoq 15mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient False Upadacitinib hemihydrate Inferred relationship Existential restriction modifier
    Upadacitinib 30mg modified-release tablets 28 tablet Has specific active ingredient False Upadacitinib hemihydrate Inferred relationship Existential restriction modifier
    Rinvoq 30mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient False Upadacitinib hemihydrate Inferred relationship Existential restriction modifier
    Rinvoq 30mg modified-release tablets (AbbVie Ltd) Has specific active ingredient False Upadacitinib hemihydrate Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start